Dirk Waldschmidt
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 31
- Pancreatic and Hepatic Oncology Research 20
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 3
- Neutropenia and Cancer Infections 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Co-authors
- Alexander Quaas (10 shared papers)Christiane J. Bruns (8 shared papers)Oliver A. Cornely (4 shared papers)Fabian Kütting (8 shared papers)Michael von Bergwelt‐Baildon (3 shared papers)Teresa Mercade Macarulla (4 shared papers)Thomas Zander (5 shared papers)Alexander Ioannis Damanakis (5 shared papers)
- Journals
- Annals of Oncology (15 papers)BMC Cancer (3 papers)European Journal of Cancer (3 papers)Journal of Clinical Oncology (3 papers)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Dirk Waldschmidt
56 papers receiving 2.6k citations
Dirk Waldschmidt's Hit Papers
Peers
Comparison fields: 5 of 76
- Hepatology 472
- Oncology 1.2k
- Cancer Research 324
- Surgery 766
- Pulmonary and Respiratory Medicine 460
Countries citing papers authored by Dirk Waldschmidt
This map shows the geographic impact of Dirk Waldschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Waldschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Waldschmidt more than expected).
Fields of papers citing papers by Dirk Waldschmidt
This network shows the impact of papers produced by Dirk Waldschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Waldschmidt. The network helps show where Dirk Waldschmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Waldschmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2023 | 699 |
| 2 | Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial Hit paper breakdown → | 2023 | 313 |
| 3 | 2017 | 242 | |
| 4 | Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma Hit paper breakdown → | 2024 | 229 |
| 5 | 2020 | 149 | |
| 6 | 2020 | 114 | |
| 7 | 2012 | 107 | |
| 8 | 2021 | 93 | |
| 9 | 2018 | 57 | |
| 10 | 2005 | 44 | |
| 11 | 2014 | 44 | |
| 12 | 2019 | 39 | |
| 13 | 2018 | 36 | |
| 14 | 2012 | 31 | |
| 15 | 2004 | 30 | |
| 16 | 2021 | 29 | |
| 17 | 2009 | 29 | |
| 18 | 2022 | 28 | |
| 19 | 2022 | 25 | |
| 20 | 2019 | 24 |
About Dirk Waldschmidt
Dirk Waldschmidt is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Epidemiology and Cancer Research, having authored 60 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer Genomics and Diagnostics (5 papers), Neuroendocrine Tumor Research Advances (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Hepatology (472 citations), Oncology (1.2k citations), Cancer Research (324 citations), Surgery (766 citations) and Pulmonary and Respiratory Medicine (460 citations). Dirk Waldschmidt has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Alexander Quaas, Christiane J. Bruns, Oliver A. Cornely, Fabian Kütting, Michael von Bergwelt‐Baildon, Teresa Mercade Macarulla, Thomas Zander, Alexander Ioannis Damanakis, Felix Popp and Florian Gebauer. Their work appears in journals such as Annals of Oncology, BMC Cancer, European Journal of Cancer, Journal of Clinical Oncology and RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.